» Articles » PMID: 34829566

The Blood-Brain Barrier, Oxidative Stress, and Insulin Resistance

Overview
Date 2021 Nov 27
PMID 34829566
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) is a network of specialized endothelial cells that regulates substrate entry into the central nervous system (CNS). Acting as the interface between the periphery and the CNS, the BBB must be equipped to defend against oxidative stress and other free radicals generated in the periphery to protect the CNS. There are unique features of brain endothelial cells that increase the susceptibility of these cells to oxidative stress. Insulin signaling can be impacted by varying levels of oxidative stress, with low levels of oxidative stress being necessary for signaling and higher levels being detrimental. Insulin must cross the BBB in order to access the CNS, levels of which are important in peripheral metabolism as well as cognition. Any alterations in BBB transport due to oxidative stress at the BBB could have downstream disease implications. In this review, we cover the interactions of oxidative stress at the BBB, how insulin signaling is related to oxidative stress, and the impact of the BBB in two diseases greatly affected by oxidative stress and insulin resistance: diabetes mellitus and Alzheimer's disease.

Citing Articles

Aging, vascular dysfunction, and the blood-brain barrier: unveiling the pathophysiology of stroke in older adults.

Alaqel S, Imran M, Khan A, Nayeem N Biogerontology. 2025; 26(2):67.

PMID: 40044939 DOI: 10.1007/s10522-025-10209-y.


Genetically predicted brain cortical structure mediates the causality between insulin resistance and cognitive impairment.

Huang C, Zhang Y, Li M, Gong Q, Yu S, Li Z Front Endocrinol (Lausanne). 2025; 15:1443301.

PMID: 39882263 PMC: 11774689. DOI: 10.3389/fendo.2024.1443301.


The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases.

Kim S, Jung U, Kim S Antioxidants (Basel). 2025; 13(12.

PMID: 39765790 PMC: 11673141. DOI: 10.3390/antiox13121462.


Studying targeted oxidation in diabetic cognitive dysfunction based on scientometrics analysis: research progress of natural product approaches.

Tu W, Xu F, Li J, Tian X, Cao L, Wang L Front Endocrinol (Lausanne). 2025; 15():1445750.

PMID: 39758348 PMC: 11695123. DOI: 10.3389/fendo.2024.1445750.


References
1.
Nation D, Sweeney M, Montagne A, Sagare A, DOrazio L, Pachicano M . Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019; 25(2):270-276. PMC: 6367058. DOI: 10.1038/s41591-018-0297-y. View

2.
Hammes H, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C . Pericytes and the pathogenesis of diabetic retinopathy. Diabetes. 2002; 51(10):3107-12. DOI: 10.2337/diabetes.51.10.3107. View

3.
Colton C, Brown C, Cook D, Needham L, Xu Q, Czapiga M . APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging. 2002; 23(5):777-85. DOI: 10.1016/s0197-4580(02)00016-7. View

4.
Livingston J, Gurny P, Lockwood D . Insulin-like effects of polyamines in fat cells. Mediation by H2O2 formation. J Biol Chem. 1977; 252(2):560-2. View

5.
Logsdon A, Erickson M, Rhea E, Salameh T, Banks W . Gut reactions: How the blood-brain barrier connects the microbiome and the brain. Exp Biol Med (Maywood). 2017; 243(2):159-165. PMC: 5788145. DOI: 10.1177/1535370217743766. View